Page last updated: 2024-10-30

lansoprazole and Mucormycosis

lansoprazole has been researched along with Mucormycosis in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Mucormycosis: Infection in humans and animals caused by any fungus in the order MUCORALES (e.g., RHIZOPUS; MUCOR; CUNNINGHAMELLA; APOPHYSOMYCES; ABSIDIA; SAKSENAEA and RHIZOMUCOR) There are many clinical types associated with infection including central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an OPPORTUNISTIC INFECTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, PY1
Tang, JH1
Chang, CC1

Other Studies

1 other study available for lansoprazole and Mucormycosis

ArticleYear
A rare cause of GI bleeding in a 56-year-old man.
    Gut, 2017, Volume: 66, Issue:6

    Topics: Anti-Ulcer Agents; Gastrointestinal Hemorrhage; Humans; Lansoprazole; Male; Middle Aged; Mucormycosi

2017